Alleviating Effect of Lafutidine on Toxicity of S-1: Adjuvant Chemotherapy of Gastric Cancer (AEOLUS).
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2018
At a glance
- Drugs Lafutidine (Primary) ; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms AEOLUS
- 20 Jan 2018 Primary endpoint has not been met. (Treatment completion rate), as reported in an abstract presented at the 2018 Gastrointestinal Cancers Symposium.
- 20 Jan 2018 Results presented at the 2018 Gastrointestinal Cancers Symposium
- 07 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.